Have to agree. I'm not sure I'm at the concerned level, but let's say I expected volume and price to show some interest post annual meeting. With that said I'd love to know the BOD's involvement in the recent offering, beyond DK's support last friday.
Me to. The product has to be good no matter who buys it. We still have a ways to go. The Kaplen buy helps but that isn't going to change anything until we see the money.
News 
Market Data 
Discover 
